Stories

A conversation with Novartis Chief Digital Officer Bertrand Bodson

Novartis investigators find genetic explanations for why some young patients relapse.

The Novartis Faculty of Scholars initiative connects academic researchers with deep knowledge and big ideas to scientists in its drug discovery labs.

The modernization and miniaturization of pharmaceutical production could expand the range of ingredients medicinal chemists use to make new drugs.

Researchers discover that networks of proteins circulating in the blood influence the development and progression of chronic diseases.

Novartis-Harvard team identifies a new type of cell that is key to the disease.

Novartis researchers are searching for more effective ways to discover drugs for neurological and psychiatric diseases.

With Nerve Live, Novartis is harnessing the power of data for the benefit of patients.

Kristen Harrington-Smith discusses her work as Vice President and Head of CAR-T US at Novartis Oncology.

With external help from Novartis, an Argentinian researcher was able to begin his search for a new medicine for tuberculosis.

Novartis has launched a comprehensive research program to help find the right combinations of therapies for the right patients.